Bank Of New York Mellon Corp Vericel Corp Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$17.65 - $27.37 $7.1 Million - $11 Million	402,161 New	402,161 $10.6 Million
Q3 2022 Nov 14, 2022	BUY	$22.62 - $32.54 $217,943 - $313,522	9,635 Added 2.36%	417,925 $9.7 Million
Q2 2022 Aug 15, 2022	SELL	$22.88 - $39.45 $1.17 Million - $2.01 Million	-51,044 Reduced 11.11%	408,290 $10.3 Million
Q1 2022 May 11, 2022	BUY	$31.69 - $43.29 $294,368 - $402,120	9,289 Added 2.06%	459,334 $17.6 Million
Q4 2021 Feb 11, 2022	SELL	$35.2 - $52.6 $626,067 - $935,543	-17,786 Reduced 3.8%	450,045 $17.7 Million
Q3 2021 Nov 12, 2021	BUY	$46.35 - $59.75 $1.09 Million - $1.4 Million	23,481 Added 5.28%	467,831 $22.8 Million
Q2 2021 Aug 11, 2021	SELL	$47.2 - $67.81 $929,179 - $1.33 Million	-19,686 Reduced 4.24%	444,350 $23.3 Million
Q1 2021 May 13, 2021	BUY	$30.93 - $59.48 $7.38 Million - $14.2 Million	238,743 Added 105.97%	464,036 $25.8 Million
Q4 2020 Feb 09, 2021	BUY	$18.53 - $31.5 $730,156 - $1.24 Million	39,404 Added 21.2%	225,293 $6.96 Million
Q3 2020 Nov 12, 2020	SELL	$14.68 - $19.12 $134,953 - $175,770	-9,193 Reduced 4.71%	185,889 $3.44 Million
Q2 2020 Aug 12, 2020	BUY	$8.5 - $15.82 $6,349 - $11,817	747 Added 0.38%	195,082 $2.7 Million
Q1 2020 May 06, 2020	SELL	$7.25 - $19.22 $287,875 - $763,168	-39,707 Reduced 16.97%	194,335 $1.78 Million
Q4 2019 Feb 14, 2020	BUY	$13.77 - $19.2 $55,685 - $77,644	4,044 Added 1.76%	234,042 $4.07 Million
Q3 2019 Nov 07, 2019	BUY	$14.93 - $19.83 $168,873 - $224,297	11,311 Added 5.17%	229,998 $3.48 Million
Q2 2019 Aug 12, 2019	SELL	$15.01 - $18.89 $306,939 - $386,281	-20,449 Reduced 8.55%	218,687 $4.13 Million
Q1 2019 May 14, 2019	SELL	$16.23 - $20.29 $101,973 - $127,482	-6,283 Reduced 2.56%	239,136 $4.19 Million
Q4 2018 Feb 11, 2019	BUY	$10.77 - $18.44 $1.22 Million - $2.09 Million	113,270 Added 85.71%	245,419 $4.27 Million
Q3 2018 Nov 09, 2018	SELL	$9.1 - $14.8 $6,724 - $10,937	-739 Reduced 0.56%	132,149 $0
Q2 2018 Aug 06, 2018	BUY	$9.6 - $14.6 $56,198 - $85,468	5,854 Added 4.61%	132,888 $1.29 Million
Q1 2018 May 15, 2018	BUY	$5.7 - $12.3 $472,222 - $1.02 Million	82,846 Added 187.49%	127,034 $1.26 Million
Q4 2017 Feb 09, 2018	BUY	$3.65 - $5.98 $161,286 - $264,244	44,188	44,188 $241,000

Others Institutions Holding VCEL

# of Institutions

279

Shares Held

48.7M

Call Options Held

91.8K

Put Options Held

23.2K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.76B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account